Medical Device News Magazine

Moorfields Eye Hospital to Open Eye Care Diagnostic Hub at Brent Cross United Kingdom

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Hammerson and Aberdeen Standard Investments (“Aberdeen”), joint owners of the flagship destination Brent Cross, announce that Moorfields Eye Hospital is to open its latest diagnostic hub at the destination. The facility, which opens in September, will be Moorfields’ third diagnostic hub outside of its central London hospital.

Moorfields will be taking 15,000 sq ft of space across two floors, in a unit previously occupied by New Look. The agreement is the latest example of how Hammerson, as joint owner and asset manager, is collaborating with businesses and public sector partners to repurpose retail space for alternative uses, including the creation of wellness and community services. The Moorfields hub will benefit from the destination’s easy access via road and public transport and unique role at the heart of the local community.

The hub will offer a monitoring service for existing Moorfields patients with retinal problems or glaucoma – two of the leading causes of preventable sight loss in the United Kingdom. Instead of having to wait to see a doctor, an appointment at the diagnostic hub aims to take patients through a series of rapid tests in around 45 minutes, allowing more patients to be seen.

These test results are then reviewed online by senior consultants who will contact patients about test outcomes and any next steps. In partnership with the National Institute for Health Research Moorfields Biomedical Research Centre and UCL, Moorfields staff will explore innovative new methods of improving efficiency.

Iain Mitchell, UK Commercial Director at Hammerson commented, “Across our portfolio, we are constantly looking at how we can respond to evolving consumer needs, and innovate and enhance our destinations. Over the last year, we have seen how important access to healthcare services is to our communities, and Brent Cross’s easily accessible location and free parking will provide a convenient and safe way for patients to access medical eye care.

The decision by Moorfields to launch its first diagnostic hub within a retail destination is the latest example of how we are repurposing spaces, diversifying the tenant mix and creating vibrant destinations which serve local communities.”

Louisa Wickham, Medical Director at Moorfields Eye Hospital added, “This new diagnostic hub at Brent Cross is a unique opportunity to provide medical eye testing to our patients in a convenient location. Our diagnostic hubs have already proved very popular with patients, and opening another allows more of them to access these services.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”